BioPerfectus Technologies Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
581
- Stock Symbol
-
688399
- Investments
-
3
- Share Price
-
$2.71
- (As of Friday Closing)
BioPerfectus Technologies General Information
Description
Jiangsu Bioperfectus Technologies Co Ltd is engaged in product development, production and sales of disease prevention and control, female genital micro-ecological testing and tumor screening. Its products and solutions involve: HPV & cervical cancer screening, Respiratory infection detection solution, Solutions for infectious diarrhea, STI detection solution for reproductive tract infections, Infectious disease testing, Maternal and child health, Disease prevention and control, Instrument, Scientific research services, and Other.
Contact Information
Website
www.bioperfectus.comCorporate Office
- BioPerfectus Technologies Industrial Park
- Number 837 Yaocheng Avenue, Jiangsu Province
- Taizhou, Jiangsu
- China
Corporate Office
- BioPerfectus Technologies Industrial Park
- Number 837 Yaocheng Avenue, Jiangsu Province
- Taizhou, Jiangsu
- China
BioPerfectus Technologies Stock Performance
As of 20-Nov-2026, BioPerfectus Technologies’s stock price is $2.71. Its current market cap is $337M with 124M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.71 | $2.93 | $2.71 - $9.11 | $337M | 124M | 1.94M | -$0.03 |
BioPerfectus Technologies Financials Summary
As of 30-Sep-2026, BioPerfectus Technologies has a trailing 12-month revenue of $45M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 337,001 | 649,865 | 270,741 | 139,047 |
| Revenue | 45,037 | 47,147 | 48,723 | 56,987 |
| EBITDA | 104 | 3,592 | 4,299 | (48,875) |
| Net Income | (3,667) | (5,712) | (279) | (52,836) |
| Total Assets | 546,808 | 508,004 | 512,315 | 551,084 |
| Total Debt | 81,017 | 53,895 | 32,951 | 24,470 |
BioPerfectus Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioPerfectus Technologies Patents
BioPerfectus Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260317838-A1 | Kit for detecting genital tract microorganism rapidly, synchronously and quantitatively, and microecological evaluation method thereof | Pending | 10-Apr-2025 | ||
| US-20260022416-A1 | Microsphere reagent for nucleic acid amplification | Pending | 30-Jul-2024 | ||
| US-20250387104-A1 | System for testing female reproductive health and diagnostic method | Pending | 11-Jul-2024 | ||
| EP-4528278-A1 | Sampling detection device | Pending | 30-Jun-2022 | ||
| EP-4528278-A4 | Sampling detection device | Pending | 30-Jun-2022 | B01L3/5023 |
BioPerfectus Technologies Signals
BioPerfectus Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioPerfectus Technologies Investments (3)
BioPerfectus Technologies’s most recent deal was a Early Stage VC with Kadwise. The deal was made on 24-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kadwise | 24-Jun-2022 | Early Stage VC | Drug Discovery | ||
| Prophet Genomics | 17-Jun-2022 | Early Stage VC | Diagnostic Equipment | ||
| Yuansong Biotechnology | Corporate | Drug Discovery |
BioPerfectus Technologies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
BioPerfectus Technologies FAQs
-
When was BioPerfectus Technologies founded?
BioPerfectus Technologies was founded in 2010.
-
Where is BioPerfectus Technologies headquartered?
BioPerfectus Technologies is headquartered in Taizhou, China.
-
What is the size of BioPerfectus Technologies?
BioPerfectus Technologies has 581 total employees.
-
What industry is BioPerfectus Technologies in?
BioPerfectus Technologies’s primary industry is Diagnostic Equipment.
-
Is BioPerfectus Technologies a private or public company?
BioPerfectus Technologies is a Public company.
-
What is BioPerfectus Technologies’s stock symbol?
The ticker symbol for BioPerfectus Technologies is 688399.
-
What is the current stock price of BioPerfectus Technologies?
As of 20-Nov-2026 the stock price of BioPerfectus Technologies is $2.71.
-
What is the current market cap of BioPerfectus Technologies?
The current market capitalization of BioPerfectus Technologies is $337M.
-
What is BioPerfectus Technologies’s current revenue?
The trailing twelve month revenue for BioPerfectus Technologies is $45M.
-
What is BioPerfectus Technologies’s annual earnings per share (EPS)?
BioPerfectus Technologies’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process